287 related articles for article (PubMed ID: 28159733)
1. Identifying functional defects in patients with immune dysregulation due to LRBA and CTLA-4 mutations.
Hou TZ; Verma N; Wanders J; Kennedy A; Soskic B; Janman D; Halliday N; Rowshanravan B; Worth A; Qasim W; Baxendale H; Stauss H; Seneviratne S; Neth O; Olbrich P; Hambleton S; Arkwright PD; Burns SO; Walker LS; Sansom DM
Blood; 2017 Mar; 129(11):1458-1468. PubMed ID: 28159733
[TBL] [Abstract][Full Text] [Related]
2. Murine LRBA deficiency causes CTLA-4 deficiency in Tregs without progression to immune dysregulation.
Burnett DL; Parish IA; Masle-Farquhar E; Brink R; Goodnow CC
Immunol Cell Biol; 2017 Oct; 95(9):775-788. PubMed ID: 28611475
[TBL] [Abstract][Full Text] [Related]
3. Immune checkpoint deficiencies and autoimmune lymphoproliferative syndromes.
Gámez-Díaz L; Grimbacher B
Biomed J; 2021 Aug; 44(4):400-411. PubMed ID: 34384744
[TBL] [Abstract][Full Text] [Related]
4. CTLA4 Message Reflects Pathway Disruption in Monogenic Disorders and Under Therapeutic Blockade.
Garcia-Perez JE; Baxter RM; Kong DS; Tobin R; McCarter M; Routes JM; Verbsky J; Jordan MB; Dutmer CM; Hsieh EWY
Front Immunol; 2019; 10():998. PubMed ID: 31156616
[TBL] [Abstract][Full Text] [Related]
5. Comparing the levels of CTLA-4-dependent biological defects in patients with LRBA deficiency and CTLA-4 insufficiency.
Catak MC; Akcam B; Bilgic Eltan S; Babayeva R; Karakus IS; Akgun G; Baser D; Bulutoglu A; Bayram F; Kasap N; Kiykim A; Hancioglu G; Kokcu Karadag SI; Kendir Demirkol Y; Ozen S; Cekic S; Ozcan D; Edeer Karaca N; Sasihuseyinoglu AS; Cansever M; Ozek Yucel E; Tamay Z; Altintas DU; Aydogmus C; Celmeli F; Cokugras H; Gulez N; Genel F; Metin A; Guner SN; Kutukculer N; Keles S; Reisli I; Kilic SS; Yildiran A; Karakoc-Aydiner E; Lo B; Ozen A; Baris S
Allergy; 2022 Oct; 77(10):3108-3123. PubMed ID: 35491430
[TBL] [Abstract][Full Text] [Related]
6. CTLA-4 Expression in CD4+ T Cells From Patients With LRBA Deficiency and Common Variable Immunodeficiency With No Known Monogenic Disease.
Azizi G; Jamee M; Yazdani R; Bagheri Y; Fayyaz F; Jadidi-Niaragh F; Abolhassani H; Aghamohammadi A
J Investig Allergol Clin Immunol; 2018 Dec; 28(6):422-424. PubMed ID: 30530390
[No Abstract] [Full Text] [Related]
7. AUTOIMMUNE DISEASE. Patients with LRBA deficiency show CTLA4 loss and immune dysregulation responsive to abatacept therapy.
Lo B; Zhang K; Lu W; Zheng L; Zhang Q; Kanellopoulou C; Zhang Y; Liu Z; Fritz JM; Marsh R; Husami A; Kissell D; Nortman S; Chaturvedi V; Haines H; Young LR; Mo J; Filipovich AH; Bleesing JJ; Mustillo P; Stephens M; Rueda CM; Chougnet CA; Hoebe K; McElwee J; Hughes JD; Karakoc-Aydiner E; Matthews HF; Price S; Su HC; Rao VK; Lenardo MJ; Jordan MB
Science; 2015 Jul; 349(6246):436-40. PubMed ID: 26206937
[TBL] [Abstract][Full Text] [Related]
8. Clinical Phenotypes and Immunological Characteristics of 18 Egyptian LRBA Deficiency Patients.
Meshaal S; El Hawary R; Adel R; Abd Elaziz D; Erfan A; Lotfy S; Hafez M; Hassan M; Johnson M; Rojas-Restrepo J; Gamez-Diaz L; Grimbacher B; Shoman W; Abdelmeguid Y; Boutros J; Galal N; El-Guindy N; Elmarsafy A
J Clin Immunol; 2020 Aug; 40(6):820-832. PubMed ID: 32506362
[TBL] [Abstract][Full Text] [Related]
9. Pulmonary manifestations of immune dysregulation in CTLA-4 haploinsufficiency and LRBA deficiency.
Krone KA; Winant AJ; Vargas SO; Platt CD; Bartnikas LM; Janssen E; Lillehei C; Lee EY; Fishman MP; Casey A
Pediatr Pulmonol; 2021 Jul; 56(7):2232-2241. PubMed ID: 33710794
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of Expression of LRBA and CTLA-4 Proteins in Common Variable Immunodeficiency Patients.
Salami F; Fekrvand S; Yazdani R; Shahkarami S; Azizi G; Bagheri Y; Delavari S; Shariati S; Mahdaviani SA; Nabavi M; Shirkani A; Abolhassani H; Samadi M; Aghamohammadi A
Immunol Invest; 2022 Feb; 51(2):381-394. PubMed ID: 33191838
[TBL] [Abstract][Full Text] [Related]
11. Different Apples, Same Tree: Visualizing Current Biological and Clinical Insights into CTLA-4 Insufficiency and LRBA and DEF6 Deficiencies.
Gámez-Díaz L; Seidel MG
Front Pediatr; 2021; 9():662645. PubMed ID: 33996698
[TBL] [Abstract][Full Text] [Related]
12. Regulation of CTLA-4 recycling by LRBA and Rab11.
Janman D; Hinze C; Kennedy A; Halliday N; Waters E; Williams C; Rowshanravan B; Hou TZ; Minogue S; Qureshi OS; Sansom DM
Immunology; 2021 Sep; 164(1):106-119. PubMed ID: 33960403
[TBL] [Abstract][Full Text] [Related]
13. Lessons from CTLA-4 deficiency and checkpoint inhibition.
Lo B; Abdel-Motal UM
Curr Opin Immunol; 2017 Dec; 49():14-19. PubMed ID: 28806575
[TBL] [Abstract][Full Text] [Related]
14. Immunological phenotype of the murine Lrba knockout.
Gámez-Díaz L; Neumann J; Jäger F; Proietti M; Felber F; Soulas-Sprauel P; Perruzza L; Grassi F; Kögl T; Aichele P; Kilimann M; Grimbacher B; Jung S
Immunol Cell Biol; 2017 Oct; 95(9):789-802. PubMed ID: 28652580
[TBL] [Abstract][Full Text] [Related]
15. What did we learn from CTLA-4 insufficiency on the human immune system?
Mitsuiki N; Schwab C; Grimbacher B
Immunol Rev; 2019 Jan; 287(1):33-49. PubMed ID: 30565239
[TBL] [Abstract][Full Text] [Related]
16. Disorders of CTLA-4 expression, how they lead to CVID and dysregulated immune responses.
Sun D; Heimall J
Curr Opin Allergy Clin Immunol; 2019 Dec; 19(6):578-585. PubMed ID: 31573993
[TBL] [Abstract][Full Text] [Related]
17. Pediatric-onset Evans syndrome: Heterogeneous presentation and high frequency of monogenic disorders including LRBA and CTLA4 mutations.
Besnard C; Levy E; Aladjidi N; Stolzenberg MC; Magerus-Chatinet A; Alibeu O; Nitschke P; Blanche S; Hermine O; Jeziorski E; Landman-Parker J; Leverger G; Mahlaoui N; Michel G; Pellier I; Suarez F; Thuret I; de Saint-Basile G; Picard C; Fischer A; Neven B; Rieux-Laucat F; Quartier P;
Clin Immunol; 2018 Mar; 188():52-57. PubMed ID: 29330115
[TBL] [Abstract][Full Text] [Related]
18. Multifocal gastric adenocarcinoma in a patient with LRBA deficiency.
Bratanič N; Kovač J; Pohar K; Trebušak Podkrajšek K; Ihan A; Battelino T; Avbelj Stefanija M
Orphanet J Rare Dis; 2017 Jul; 12(1):131. PubMed ID: 28720148
[TBL] [Abstract][Full Text] [Related]
19. Immune deficiency and autoimmunity in patients with CTLA-4 (CD152) mutations.
Verma N; Burns SO; Walker LSK; Sansom DM
Clin Exp Immunol; 2017 Oct; 190(1):1-7. PubMed ID: 28600865
[TBL] [Abstract][Full Text] [Related]
20. Monogenic forms of common variable immunodeficiency and implications on target therapeutic approaches.
Tessarin G; Baronio M; Lougaris V
Curr Opin Allergy Clin Immunol; 2023 Dec; 23(6):461-466. PubMed ID: 37767915
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]